Australia becomes first nation to legalise prescription psychedelics
Australia has become the first country to legalise MDMA and psilocybin for the treatment of mental health conditions at a national level.
Australia has become the first country to legalise MDMA and psilocybin for the treatment of mental health conditions at a national level.
The Voices for Smarter Choices protest will call for the rescheduling of psychedelics on 9 July 2023 at Parliament Square Garden in London.
The U.S. Food and Drug Administration (FDA) has published its first-ever guidance document on clinical trials using psychedelic drugs.
Psychedelic drugs can reopen "critical periods" in the brain, during which mammals are highly receptive to acquiring new skills and knowledge, according to new research.
Johns Hopkins Centre for Psychedelic and Consciousness Research (CPRC) has made a significant announcement regarding its leadership.
Processing your application
There was an error sending the email. Please try again.
Check your inbox and click the link to confirm your subscription.